Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin a from Clostridium difficile

被引:40
作者
Ward, SJ
Douce, G
Dougan, G
Wren, BW
机构
[1] St Bartholomews & Royal London Sch Med & Dent, Dept Microbiol, Microbial Pathogenic Res Grp, London EC1A 7BE, England
[2] Univ London Imperial Coll Sci Technol & Med, Dept Biochem, London SW7 2AZ, England
基金
英国惠康基金;
关键词
D O I
10.1128/IAI.67.10.5124-5132.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fourteen of the 38 C-terminal repeats from Clostridium difficile toxin A (14CDTA) were cloned and expressed either with an N-terminal polyhistidine tag (14CDTA-HIS) or fused to the nontoxic binding domain from tetanus toxin (14CDTA-TETC). The recombinant proteins were successfully purified by bovine thyroglobulin affinity chromatography. Both C. difficile toxin A fusion proteins bound to known toxin A ligands present on the surface of rabbit erythrocytes. Intranasal immunization of BALB/c mice with three separate 10-mu g doses of 14CDTA-HIS or -TETC generated significant levels of anti-toxin A serum antibodies compared to central animals. The coadministration of the mucosal adjuvant heat labile toxin (LT) from Escherichia coli (1 mu g) significantly increased the anti-toxin B response in the serum and at the mucosal surface. Importantly, the local and systemic antibodies generated neutralized toxin A cytotoxicity. Impressive systemic and mucosal anti-toxin A responses were also seen following coadministration of 14CDTA-TETC with LTR72, an LT derivative with reduced toxicity which shows potential as a mucosal adjuvant for humans.
引用
收藏
页码:5124 / 5132
页数:9
相关论文
共 54 条
[11]   Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli [J].
Douce, G ;
Giuliani, MM ;
Giannelli, V ;
Pizza, MG ;
Rappuoli, R ;
Dougan, G .
VACCINE, 1998, 16 (11-12) :1065-1073
[12]   MUTANTS OF ESCHERICHIA-COLI HEAT-LABILE TOXIN LACKING ADP-RIBOSYLTRANSFERASE ACTIVITY ACT AS NONTOXIC, MUCOSAL ADJUVANTS [J].
DOUCE, G ;
TURCOTTE, C ;
CROPLEY, I ;
ROBERTS, M ;
PIZZA, M ;
DOMENGHINI, M ;
RAPPUOLI, R ;
DOUGAN, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1644-1648
[13]   MOLECULAR CHARACTERIZATION OF THE CLOSTRIDIUM-DIFFICILE TOXIN-A GENE [J].
DOVE, CH ;
WANG, SZ ;
PRICE, SB ;
PHELPS, CJ ;
LYERLY, DM ;
WILKINS, TD ;
JOHNSON, JL .
INFECTION AND IMMUNITY, 1990, 58 (02) :480-488
[14]   IMMUNIZATION OF MICE AGAINST TETANUS WITH FRAGMENTS OF TETANUS TOXIN SYNTHESIZED IN ESCHERICHIA-COLI [J].
FAIRWEATHER, NF ;
LYNESS, VA ;
MASKELL, DJ .
INFECTION AND IMMUNITY, 1987, 55 (11) :2541-2545
[15]   TREATMENT OF ANTIBIOTIC-ASSOCIATED CLOSTRIDIUM-DIFFICILE COLITIS WITH ORAL VANCOMYCIN - COMPARISON OF 2 DOSAGE REGIMENS [J].
FEKETY, R ;
SILVA, J ;
KAUFFMAN, C ;
BUGGY, B ;
DEERY, HG .
AMERICAN JOURNAL OF MEDICINE, 1989, 86 (01) :15-19
[16]   IDENTIFICATION OF CLOSTRIDIUM DIFFICILE AS A CAUSE OF PSEUDOMEMBRANOUS COLITIS [J].
GEORGE, RH ;
SYMONDS, JM ;
DIMOCK, F ;
BROWN, JD ;
ARABI, Y ;
SHINAGAWA, N ;
KEIGHLEY, MRB ;
ALEXANDERWILLIAMS, J ;
BURDON, DW .
BRITISH MEDICAL JOURNAL, 1978, 1 (6114) :695-695
[17]   Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins [J].
Giannasca, PJ ;
Boden, JA ;
Monath, TP .
INFECTION AND IMMUNITY, 1997, 65 (10) :4288-4298
[18]   Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters [J].
Giannasca, PJ ;
Zhang, ZX ;
Lei, WD ;
Boden, JA ;
Giel, MA ;
Monath, TP ;
Thomas, WD .
INFECTION AND IMMUNITY, 1999, 67 (02) :527-538
[19]   Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity [J].
Giuliani, MM ;
Del Giudice, G ;
Giannelli, V ;
Dougan, G ;
Douce, G ;
Rappuoli, R ;
Pizza, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (07) :1123-1132
[20]   THE EPIDEMIOLOGY OF CLOSTRIDIUM-DIFFICILE WITH USE OF A TYPING SCHEME - NOSOCOMIAL ACQUISITION AND CROSS-INFECTION AMONG IMMUNOCOMPROMISED PATIENTS [J].
HEARD, SR ;
OFARRELL, S ;
HOLLAND, D ;
CROOK, S ;
BARNETT, MJ ;
TABAQCHALI, S .
JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (01) :159-162